Publicacions en què col·labora amb José Javier Meana Martínez (14)

2023

  1. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects

    Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487

2022

  1. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

    Addiction Biology, Vol. 27, Núm. 6

2020

  1. Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia

    Frontiers in Pharmacology, Vol. 11

2019

  1. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus

    Neuropharmacology, Vol. 158

2018

  1. Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway

    Neuropsychopharmacology, Vol. 43, Núm. 10, pp. 2028-2035

2017

  1. The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia

    European Neuropsychopharmacology, Vol. 27, Núm. 2, pp. 180-191

2016

  1. Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex

    Frontiers in Pharmacology, Vol. 7, Núm. NOV

  2. Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study

    Psychopharmacology, Vol. 233, Núm. 23-24, pp. 3861-3867

2013

  1. Antidepressant-like properties of three new α2-adrenoceptor antagonists

    Neuropharmacology, Vol. 65, pp. 13-19

  2. Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.

    Translational psychiatry, Vol. 3

  3. Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders

    Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders (Springer New York), pp. 213-238

2012

  1. Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: Down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment

    International Journal of Neuropsychopharmacology, Vol. 15, Núm. 5, pp. 573-588

2009

  1. Immunodensity and mRNA expression of A2A adenosine, D 2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: Effect of antipsychotic treatment

    Psychopharmacology, Vol. 206, Núm. 2, pp. 313-324

2008

  1. Gene expression patterns in brain cortex of three different animal models of depression

    Genes, Brain and Behavior, Vol. 7, Núm. 6, pp. 649-658